# Ribosome in Cell: Structure, Function, and Synthesis

## Introduction to the Ribosome in Cell

The ribosome is the macromolecular machine responsible for protein synthesis in all living cells. It translates the genetic information encoded in messenger RNA (mRNA) into polypeptide chains, a process known as translation. Without ribosomes, cells could not produce the enzymes, structural proteins, and regulatory factors that sustain life. The ribosome is one of the most abundant cellular components; a single *Escherichia coli* cell contains approximately 20,000 ribosomes, while a mammalian cell can harbor millions.

### Historical Discovery

Ribosomes were first observed in the 1950s by George Palade, who used electron microscopy to identify dense, granular particles attached to the endoplasmic reticulum (ER) in pancreatic cells. These particles, initially called "Palade granules," were later shown to be the sites of protein synthesis. In 1955, Palade published his landmark findings, and by the 1960s, researchers had established that ribosomes consist of RNA and protein and that they read mRNA codons to assemble amino acids in the order specified by the genetic code. The term "ribosome" was coined in 1958 by Richard B. Roberts at a symposium, reflecting the particle's composition of ribonucleic acid and its role as a "some" or body within the cell.

### Basic Composition

A ribosome is composed of two subunits: a large subunit and a small subunit. Each subunit contains ribosomal RNA (rRNA) and ribosomal proteins. The rRNA provides the structural scaffold and, critically, the catalytic activity for peptide bond formation. The proteins stabilize the structure and assist in mRNA binding and translocation. In prokaryotes, the ribosome sediments at 70S (Svedberg units), with a large 50S subunit and a small 30S subunit. Eukaryotic ribosomes are larger, sedimenting at 80S, with a 60S large subunit and a 40S small subunit. The Svedberg unit reflects the rate of sedimentation in a centrifugal field, which depends on both size and shape, so the values are not additive (50S + 30S = 70S, not 80S).

## Ribosome Structure and Composition

The ribosome is a ribonucleoprotein complex, meaning it contains both RNA and protein. The rRNA constitutes about 60% of the ribosome's mass in prokaryotes and about 50% in eukaryotes. The remainder is protein. The three-dimensional architecture of the ribosome is highly conserved across all domains of life, reflecting its ancient evolutionary origin.

### Prokaryotic vs. Eukaryotic Ribosomes

Prokaryotic ribosomes (70S) are smaller and simpler than eukaryotic ribosomes (80S). The 30S small subunit contains the 16S rRNA (approximately 1,500 nucleotides) and 21 proteins (designated S1–S21). The 50S large subunit contains the 23S rRNA (approximately 2,900 nucleotides), the 5S rRNA (120 nucleotides), and 34 proteins (designated L1–L34). The 23S rRNA is the peptidyl transferase center (PTC), the catalytic site where peptide bonds are formed.

Eukaryotic ribosomes are larger and contain additional rRNA and proteins. The 40S small subunit contains the 18S rRNA (approximately 1,900 nucleotides) and 33 proteins. The 60S large subunit contains the 28S rRNA (approximately 4,700 nucleotides), the 5.8S rRNA (160 nucleotides), the 5S rRNA (120 nucleotides), and 47 proteins. The additional rRNA and proteins in eukaryotic ribosomes provide increased surface area for interactions with eukaryotic-specific translation factors and regulatory elements.

Mitochondrial and chloroplast ribosomes are distinct from both cytoplasmic and prokaryotic ribosomes. They resemble prokaryotic ribosomes in size (55S–70S) and are sensitive to many antibiotics that target bacterial ribosomes, which is relevant to the side effects of certain antimicrobials.

### Key Structural Sites: A, P, and E sites

Each ribosome has three tRNA-binding sites on the large subunit, positioned over the small subunit's mRNA-binding channel:

- **A site (aminoacyl site):** The entry site where an aminoacyl-tRNA (a tRNA charged with its cognate amino acid) binds, guided by codon–anticodon base pairing with the mRNA.
- **P site (peptidyl site):** The site where the tRNA carrying the growing polypeptide chain resides. The peptidyl-tRNA is positioned here before peptide bond formation.
- **E site (exit site):** The site where deacylated tRNA (tRNA that has released its amino acid) briefly binds before being released from the ribosome.

The mRNA passes through a channel in the small subunit, with the codons sequentially exposed at the A site. The decoding center, located in the small subunit, monitors codon–anticodon pairing and ensures translational fidelity. The peptidyl transferase center, located in the large subunit, catalyzes peptide bond formation. For a detailed visual reference, see the [Ribosome Diagram](/knowledge/molecular-biology/ribosome-diagram) and [Ribosome Picture](/knowledge/molecular-biology/ribosome-picture).

## Location of Ribosomes in the Cell

Ribosomes are found in two main locations within the cytoplasm: free in the cytosol and bound to the cytoplasmic face of the rough endoplasmic reticulum (RER). The location of a ribosome at any given time is determined by the mRNA it is translating and the signal sequence present in the nascent polypeptide.

### Free Ribosomes

Free ribosomes are suspended in the cytosol. They synthesize proteins that remain in the cytosol, are imported into the nucleus, mitochondria, chloroplasts, or peroxisomes, or are destined for the cytosolic face of membranes. Examples include glycolytic enzymes, cytoskeletal proteins, and [transcription factors](/knowledge/molecular-biology/transcription-factor). Free ribosomes are not permanently free; they can attach to the ER when they begin translating an mRNA that encodes a protein with a signal peptide.

### Bound Ribosomes

Bound ribosomes are attached to the cytoplasmic surface of the rough ER. The attachment is mediated by the signal recognition particle (SRP), a ribonucleoprotein complex that recognizes the N-terminal signal peptide (typically 15–30 hydrophobic amino acids) as it emerges from the ribosome. SRP binds to the signal peptide, pauses translation, and delivers the ribosome–mRNA–nascent chain complex to the SRP receptor on the ER membrane. Translation resumes, and the nascent polypeptide is translocated into the ER lumen through the Sec61 translocon channel. Proteins synthesized by bound ribosomes include secreted proteins, lysosomal enzymes, and integral membrane proteins.

The distinction between free and bound ribosomes is functional, not structural. The ribosomes themselves are identical; the difference lies in the mRNA being translated. A ribosome translating an mRNA without a signal peptide remains free, while one translating an mRNA with a signal peptide becomes bound. This is a common point of confusion, and the [Difference Between Lysosome and Ribosome](/knowledge/molecular-biology/difference-between-lysosome-and-ribosome) is a useful comparison for understanding how these organelles differ in origin and function.

## The Process of Translation: How Ribosomes Synthesize Proteins

Translation occurs in three main stages: initiation, elongation, and termination. Each stage requires specific protein factors, GTP hydrolysis, and precise conformational changes in the ribosome. The overall process is described in detail in the [Ribosome Translation](/knowledge/molecular-biology/ribosome-translation) resource.

### Initiation

Initiation assembles the ribosome–mRNA–initiator tRNA complex at the start codon. In prokaryotes, the small (30S) subunit binds to the Shine–Dalgarno sequence (a purine-rich sequence, typically AGGAGG, located 6–10 nucleotides upstream of the start codon AUG) via complementary base pairing with the 16S rRNA. The initiator tRNA, charged with N-formylmethionine (fMet-tRNAᶠᴹᵉᵗ), binds to the P site. Initiation factor 3 (IF3) prevents premature association of the large subunit. Initiation factor 1 (IF1) binds to the A site to block tRNA entry. Initiation factor 2 (IF2), a GTPase, delivers fMet-tRNAᶠᴹᵉᵗ to the P site. GTP hydrolysis by IF2 triggers the release of all three initiation factors and the association of the 50S subunit, forming the 70S initiation complex.

In eukaryotes, initiation is more complex. The 40S subunit, along with eukaryotic initiation factors (eIFs), binds to the 5′ cap of the mRNA and scans along the 5′ untranslated region (UTR) until it encounters the first AUG codon in a favorable context (the Kozak consensus sequence, GCCRCCAUGG). The initiator tRNA, charged with methionine (Met-tRNAᵢ), is delivered by eIF2 in a GTP-dependent manner. eIF4F, a cap-binding complex, unwinds secondary structure in the 5′ UTR. Once the AUG is recognized, eIF5 triggers GTP hydrolysis by eIF2, and the 60S subunit joins to form the 80S initiation complex.

### Elongation

Elongation is a cyclic process that adds amino acids one at a time to the growing polypeptide chain. Each cycle involves three steps:

1. **Codon recognition and aminoacyl-tRNA delivery:** An aminoacyl-tRNA is delivered to the A site as a ternary complex with elongation factor Tu (EF-Tu in prokaryotes, eEF1A in eukaryotes) and GTP. If the anticodon matches the mRNA codon, GTP is hydrolyzed and EF-Tu is released. If the match is incorrect, the tRNA dissociates, and the proofreading mechanism rejects it.
2. **Peptide bond formation:** The peptidyl transferase center of the large subunit catalyzes the transfer of the polypeptide chain from the P-site tRNA to the amino group of the A-site aminoacyl-tRNA. This reaction forms a new peptide bond and leaves the P-site tRNA deacylated. The 23S rRNA (or 28S rRNA in eukaryotes) is the catalyst; no protein is directly involved in this reaction.
3. **Translocation:** The ribosome moves one codon (three nucleotides) along the mRNA. The deacylated tRNA moves from the P site to the E site, the peptidyl-tRNA moves from the A site to the P site, and the mRNA advances by three nucleotides. Translocation is catalyzed by elongation factor G (EF-G in prokaryotes, eEF2 in eukaryotes), a GTPase. GTP hydrolysis provides the energy for the conformational change.

The elongation cycle repeats at a rate of approximately 15–20 amino acids per second in bacteria at 37°C. The energy cost is two GTP molecules per amino acid added (one for EF-Tu, one for EF-G), in addition to the ATP used to charge the tRNA.

### Termination

Termination occurs when a stop codon (UAA, UAG, or UGA) enters the A site. No tRNA recognizes these codons. Instead, release factors (RFs) bind. In prokaryotes, RF1 recognizes UAA and UAG, while RF2 recognizes UAA and UGA. RF3, a GTPase, facilitates the release of RF1/RF2. In eukaryotes, a single release factor, eRF1, recognizes all three stop codons, and eRF3, a GTPase, stimulates peptide release. The release factor mimics a tRNA, fitting into the A site and triggering the peptidyl transferase center to hydrolyze the ester bond between the polypeptide and the P-site tRNA. This releases the completed polypeptide. The ribosome then dissociates into its subunits, aided by ribosome recycling factor (RRF) in prokaryotes, and is ready to initiate another round of translation.

## Ribosome Function Beyond Translation

The ribosome is not merely a passive protein factory. It actively participates in protein quality control, co-translational folding, and cellular stress responses.

### Co-translational Folding

Nascent polypeptides begin to fold while still attached to the ribosome. The ribosome exit tunnel, approximately 80–100 Å long and 15–20 Å wide, accommodates the nascent chain and allows the formation of secondary structures, such as α-helices, before the polypeptide emerges. Chaperones, including trigger factor in bacteria and the nascent polypeptide-associated complex (NAC) in eukaryotes, bind to the emerging chain and facilitate proper folding. The ribosome itself can influence folding kinetics by modulating the rate of translation; synonymous codon usage, which affects tRNA availability and translation speed, can alter co-translational folding outcomes.

### Ribosome Quality Control

Ribosomes monitor the integrity of both the mRNA and the nascent polypeptide. When a ribosome stalls (due to a truncated mRNA, a rare codon, or a structured RNA element) it triggers quality control pathways. In no-go decay (NGD), the stalled ribosome is recognized by factors such as Dom34/Hbs1 in eukaryotes, which split the ribosome and target the mRNA for degradation. In nonstop decay (NSD), ribosomes that reach the end of an mRNA lacking a stop codon are rescued by the ribosome quality control (RQC) complex, which adds a C-terminal alanine and threonine tail (the "CAT tail") to the nascent chain, targeting it for proteasomal degradation. Ribosome-associated quality control (RQC) also detects aberrant nascent chains and recruits the E3 ubiquitin ligase Listerin (LTN1) to ubiquitinate the stalled polypeptide, marking it for destruction.

Ribosomes also sense cellular stress. Under amino acid starvation, the kinase GCN2 phosphorylates eIF2α, reducing global translation initiation while selectively increasing translation of stress-responsive mRNAs such as ATF4. This integrated stress response (ISR) allows the cell to conserve resources and adapt to adverse conditions.

## Methods to Study Ribosomes

Several techniques have been developed to study ribosome structure, function, and dynamics. These methods have revealed the molecular details of translation and its regulation.

### Cryo-EM

Cryogenic electron microscopy (cryo-EM) has revolutionized the study of ribosome structure. In cryo-EM, ribosomes are rapidly frozen in a thin layer of vitreous ice and imaged in a transmission electron microscope. Thousands of particle images are computationally averaged to produce a three-dimensional reconstruction at near-atomic resolution. Cryo-EM has captured ribosomes in various functional states (during initiation, elongation, and termination) revealing the conformational changes that accompany each step. The 2009 Nobel Prize in Chemistry was awarded to Venkatraman Ramakrishnan, Thomas A. Steitz, and Ada E. Yonath for their work on ribosome structure using [X-ray crystallography](/knowledge/molecular-biology/x-ray-crystallography), and cryo-EM has since pushed resolution to below 2 Å, allowing visualization of individual water molecules and metal ions in the ribosome.

### [Ribosome Profiling](/knowledge/molecular-biology/ribosome-profiling)

[Ribosome profiling](/knowledge/molecular-biology/ribosome-profiling) (also called Ribo-seq) is a high-throughput technique that measures the positions of ribosomes on mRNAs genome-wide. The method involves:

1. Treating cells with a translation inhibitor (e.g., cycloheximide) to freeze ribosomes on mRNAs.
2. Digesting unprotected mRNA with nuclease, leaving ribosome-protected fragments (RPFs) of ~28–30 nucleotides.
3. Purifying the RPFs, converting them to a cDNA library, and sequencing them.

The resulting data reveal which mRNAs are being translated, the positions of ribosomes along each mRNA, and the rate of translation. Ribosome profiling has identified upstream open reading frames (uORFs), translation of non-canonical start sites, and differential translation under stress conditions. For a deeper dive, see [Ribosome Profiling](/knowledge/molecular-biology/ribosome-profiling).

### Polysome Analysis

Polysome analysis separates ribosomes and their associated mRNAs by sucrose [density gradient centrifugation](/knowledge/molecular-biology/density-gradient-centrifugation). Cells are lysed in the presence of translation inhibitors, and the lysate is layered on a 10–50% sucrose gradient. After ultracentrifugation (typically 35,000–40,000 rpm for 2–3 hours), fractions are collected and monitored by UV absorbance at 254 nm. The resulting profile shows peaks corresponding to the 40S and 60S subunits, the 80S monosome, and polysomes (mRNAs with multiple ribosomes). The ratio of polysomes to monosomes indicates the overall translation activity of the cell. Polysome analysis is often combined with RNA sequencing to identify which mRNAs are actively translated.

## Ribosome Biogenesis and Assembly

Ribosome biogenesis is a complex, energy-intensive process that consumes a significant fraction of the cell's resources. In rapidly growing bacteria, ribosome synthesis accounts for up to 40% of total cellular energy expenditure. In eukaryotes, ribosome biogenesis occurs primarily in the nucleolus, a specialized nuclear compartment.

### rRNA Transcription and Processing

In eukaryotes, the rRNA genes are present in tandem repeats on chromosomes 13, 14, 15, 21, and 22 (the nucleolar organizer regions). RNA polymerase I transcribes a single 47S precursor rRNA (approximately 13,000 nucleotides) that contains the 18S, 5.8S, and 28S rRNA sequences, separated by internal transcribed spacers (ITS1 and ITS2) and flanked by external transcribed spacers (5′ ETS and 3′ ETS). The 5S rRNA is transcribed separately by RNA polymerase III.

The 47S precursor is processed through a series of endonucleolytic and exonucleolytic cleavages. The U3 small nucleolar ribonucleoprotein (snoRNP) complex, which contains the U3 snoRNA and associated proteins, directs the early cleavage events. Over 200 small nucleolar RNAs (snoRNAs) guide the modification of rRNA, including 2′-O-methylation and pseudouridylation. These modifications, catalyzed by fibrillarin and dyskerin, respectively, are essential for rRNA stability and ribosome function. The mature rRNAs are 18S (small subunit), and 28S, 5.8S, and 5S (large subunit).

### Import of Ribosomal Proteins

Ribosomal proteins are synthesized in the cytoplasm by free ribosomes and imported into the nucleus through nuclear pore complexes. Each ribosomal protein contains a nuclear localization signal (NLS) that is recognized by importin-β family receptors. Once in the nucleolus, ribosomal proteins assemble with the rRNA in a hierarchical, ordered manner. Assembly factors, including ATP-dependent RNA helicases and GTPases, facilitate the correct folding and assembly of the ribonucleoprotein complex. The pre-ribosomal particles are then exported to the cytoplasm through the nuclear pore complex, where final maturation steps occur, including the removal of remaining assembly factors and the activation of translation competence.

In bacteria, ribosome biogenesis is simpler and occurs entirely in the cytoplasm. The rRNAs are transcribed as a single polycistronic precursor (e.g., the *rrnB* operon in *E. coli* encodes 16S, 23S, and 5S rRNA), processed by RNase III and other ribonucleases, and assembled with ribosomal proteins in a defined order. The assembly process can be reconstituted in vitro, providing a model system for studying the principles of macromolecular assembly.

## Ribosomes and Antibiotics: Targeting the Ribosome

The ribosome is a major target for antibiotics because of the significant structural differences between prokaryotic and eukaryotic ribosomes. Many clinically important antibiotics selectively inhibit bacterial protein synthesis by binding to the 70S ribosome while leaving the 80S ribosome largely unaffected.

### Examples of Antibiotics

| Antibiotic | Target Site | Mechanism | Clinical Use |
|------------|-------------|-----------|--------------|
| Tetracycline | 30S subunit A site | Blocks aminoacyl-tRNA binding | Broad-spectrum; acne, respiratory infections |
| Aminoglycosides (e.g., streptomycin, gentamicin) | 30S subunit decoding center | Induces misreading of mRNA; inhibits initiation | Severe Gram-negative infections |
| Macrolides (e.g., erythromycin, azithromycin) | 50S subunit exit tunnel | Blocks peptide elongation by occluding the tunnel | Respiratory and soft tissue infections |
| Chloramphenicol | 50S subunit peptidyl transferase center | Inhibits peptide bond formation | Meningitis, typhoid fever (reserved use) |
| Clindamycin | 50S subunit | Blocks peptide bond formation | Anaerobic infections |
| Linezolid | 50S subunit PTC | Inhibits initiation complex formation | MRSA, VRE infections |
| Puromycin | A site (mimics aminoacyl-tRNA) | Causes premature chain termination | Research tool; not used clinically |

### Selective Toxicity

The selectivity of these antibiotics arises from structural differences between prokaryotic and eukaryotic ribosomes. For example, macrolides bind to a specific pocket in the 23S rRNA exit tunnel that is absent in the eukaryotic 28S rRNA. Aminoglycosides interact with the prokaryotic 16S rRNA decoding center at positions that differ from the eukaryotic 18S rRNA. The clinical utility of these drugs depends on this differential binding. However, some antibiotics, such as chloramphenicol, can inhibit mitochondrial ribosomes (which resemble bacterial ribosomes), leading to dose-dependent bone marrow suppression, a serious side effect. Understanding the molecular basis of antibiotic action on the ribosome is essential for developing new antimicrobials and predicting drug toxicity.

## Common Misconceptions and Study Tips

Students frequently encounter several conceptual difficulties when learning about ribosomes. Addressing these early can prevent confusion later.

### Misconception: Ribosomes are membrane-bound

Ribosomes are not membrane-bound organelles. They are large ribonucleoprotein complexes that exist free in the cytosol or are attached to the cytoplasmic surface of the rough ER. The attachment to the ER is mediated by the nascent polypeptide and the SRP, not by a membrane surrounding the ribosome. Ribosomes lack a lipid bilayer and are not considered organelles in the classical sense.

### Misconception: All ribosomes are the same

While the core structure and function of ribosomes are conserved, there are significant differences between prokaryotic and eukaryotic ribosomes, as detailed above. Additionally, ribosomes can be heterogeneous within a single cell. Specialized ribosomes, containing variant ribosomal proteins or rRNA modifications, can preferentially translate specific subsets of mRNAs. For example, the ribosomal protein RPL38 in mammals is required for the translation of Hox mRNAs during embryonic development, and its absence leads to skeletal patterning defects. This concept of "ribosome heterogeneity" is an active area of research.

### Misconception: The ribosome is just a passive scaffold

The ribosome is a dynamic machine. The rRNA catalyzes peptide bond formation, and the ribosome undergoes large-scale conformational changes during each elongation cycle. It also participates in quality control, co-translational folding, and stress sensing. The ribosome is not merely a platform where translation factors act; it is an active participant in the process.

### Study Tips

1. **Draw the ribosome:** Sketch the large and small subunits, label the A, P, and E sites, and indicate the mRNA path. Repeat until you can do it from memory.
2. **Compare and contrast:** Make a table comparing prokaryotic and eukaryotic ribosomes (sedimentation coefficients, rRNA sizes, protein numbers, antibiotic sensitivity). This is a common exam question.
3. **Trace the elongation cycle:** Write out the steps of elongation, including the factors and GTP hydrolysis events, and track the movement of tRNAs through the A, P, and E sites.
4. **Connect structure to function:** When studying antibiotics, ask why each drug is selective. The answer is always in the structural differences between 70S and 80S ribosomes.
5. **Use mnemonics:** For the three sites, remember "A for Aminoacyl (entry), P for Peptidyl (polypeptide), E for Exit."

## Frequently Asked Questions

### What is a ribosome in a cell?

A ribosome is a large ribonucleoprotein complex composed of ribosomal RNA (rRNA) and ribosomal proteins. It is the site of protein synthesis, where the genetic information in messenger RNA (mRNA) is translated into a polypeptide chain. Ribosomes are found in all living cells, in both prokaryotes and eukaryotes, and are essential for cell function. For a formal definition, see [Ribosome Definition](/knowledge/molecular-biology/ribosome-definition).

### What is the function of ribosomes in a cell?

The primary function of ribosomes is to synthesize proteins by translating the [nucleotide sequence](/knowledge/molecular-biology/nucleotide-sequence) of mRNA into an [amino acid sequence](/blog/guides/amino-acid-sequence). Ribosomes catalyze peptide bond formation, ensure the accuracy of codon–anticodon pairing, and coordinate the binding of tRNAs, translation factors, and the mRNA. Beyond translation, ribosomes participate in co-translational folding, quality control, and cellular stress responses. For more on how ribosomes make proteins, see [Ribosome Make Protein](/knowledge/molecular-biology/ribosome-make-protein).

### Where are ribosomes found in a cell?

Ribosomes are found in the cytoplasm, either free in the cytosol or bound to the cytoplasmic surface of the rough endoplasmic reticulum (RER). Free ribosomes synthesize proteins that remain in the cytosol or are targeted to organelles such as the nucleus, mitochondria, or peroxisomes. Bound ribosomes synthesize proteins destined for secretion, the plasma membrane, or lysosomes. Ribosomes are also present in mitochondria and chloroplasts, where they synthesize a small number of organellar proteins.

### Are ribosomes found in both prokaryotic and eukaryotic cells?

Yes, ribosomes are found in all cells. Prokaryotic ribosomes are 70S particles (50S + 30S subunits), while eukaryotic cytoplasmic ribosomes are 80S particles (60S + 40S subunits). Mitochondrial and chloroplast ribosomes in eukaryotic cells resemble prokaryotic ribosomes in size and antibiotic sensitivity, reflecting their endosymbiotic origin.

### What is the difference between free and bound ribosomes?

Free and bound ribosomes are structurally identical. The difference is functional: free ribosomes translate mRNAs that encode cytosolic proteins, while bound ribosomes translate mRNAs that encode proteins with a signal peptide, which directs the ribosome to the ER membrane. The signal recognition particle (SRP) recognizes the signal peptide as it emerges from the ribosome and delivers the complex to the ER. Once the protein is translocated into the ER, the ribosome can return to the free pool.

### How do ribosomes know which protein to make?

Ribosomes do not "know" which protein to make; they simply translate the mRNA that is bound to them. The sequence of codons in the mRNA determines the [amino acid sequence](/blog/guides/amino-acid-sequence) of the protein. The ribosome reads the mRNA in the 5′ to 3′ direction, and each codon specifies a particular amino acid (or a stop signal). The mRNA itself is produced by transcription of a gene, so the information ultimately flows from DNA to RNA to protein.

### Why are ribosomes important for antibiotics?

Many antibiotics target the bacterial ribosome because it is essential for bacterial growth and structurally different from the eukaryotic ribosome. Drugs such as tetracyclines, aminoglycosides, macrolides, and chloramphenicol bind to specific sites on the 70S ribosome and inhibit protein synthesis. Because the eukaryotic 80S ribosome is not affected at therapeutic concentrations, these drugs can kill or inhibit bacteria without harming the host. The structural differences between prokaryotic and eukaryotic ribosomes are the basis of this selective toxicity.

## Key Takeaways

- Ribosomes are ribonucleoprotein complexes composed of rRNA and proteins, with two subunits (large and small) that assemble during translation.
- Prokaryotic ribosomes are 70S (50S + 30S); eukaryotic cytoplasmic ribosomes are 80S (60S + 40S); mitochondrial and chloroplast ribosomes resemble prokaryotic ones.
- Ribosomes have three tRNA-binding sites: A (aminoacyl), P (peptidyl), and E (exit), and the catalytic peptidyl transferase center is formed by rRNA, not protein.
- Free ribosomes synthesize cytosolic proteins; bound ribosomes synthesize secretory and membrane proteins, with the distinction determined by the mRNA's signal peptide.
- Translation proceeds through initiation, elongation, and termination, requiring GTP-hydrolyzing factors and precise conformational changes in the ribosome.
- Ribosomes also perform quality control, co-translational folding, and stress sensing, and are the targets of many clinically important antibiotics.
- Ribosome biogenesis in eukaryotes occurs in the nucleolus, involving rRNA transcription by RNA polymerase I, processing by snoRNPs, and ordered assembly with ribosomal proteins.

## Further Reading

- Istiaq A, Ohta K. *Ribosome-Induced Cellular Multipotency, an Emerging Avenue in Cell Fate Reversal*. Cells. 2021. [PubMed 34571922](https://doi.org/10.3390/cells10092276)
- Chung SS et al. *Ribosome Stalling of N-Linked Glycoproteins in Cell-Free Extracts*. ACS synthetic biology. 2022. [PubMed 36399685](https://doi.org/10.1021/acssynbio.2c00311)
- DeMott CM et al. *Ribosome Mediated Quinary Interactions Modulate In-Cell Protein Activities*. Biochemistry. 2017. [PubMed 28715177](https://doi.org/10.1021/acs.biochem.7b00613)
- Sharifi S, da Costa HFR, Bierhoff H. *The circuitry between ribosome biogenesis and translation in stem cell function and ageing*. Mechanisms of ageing and development. 2020. [PubMed 32531294](https://doi.org/10.1016/j.mad.2020.111282)
- Zhang L et al. *Regulatory Roles of Mitochondrial Ribosome in Lung Diseases and Single Cell Biology*. Advances in experimental medicine and biology. 2017. [PubMed 29178077](https://doi.org/10.1007/978-981-10-6674-0_13)
- Susanto TT et al. *RAPIDASH: Tag-free enrichment of ribosome-associated proteins reveals composition dynamics in embryonic tissue, cancer cells, and macrophages*. Molecular cell. 2024. [PubMed 39260367](https://doi.org/10.1016/j.molcel.2024.08.023)

## Related Clinical & Scientific Guides

* [MAPK Pathway: Mechanism, Function, and Clinical Relevance](/knowledge/molecular-biology/mapk-pathway)
* [Mammalian Cell Culture Bioreactors: A Practical Guide](/knowledge/molecular-biology/mammalian-cell-culture-bioreactor)
* [Nucleotide Formation: Biosynthesis and Assembly of DNA/RNA Building Blocks](/knowledge/molecular-biology/nucleotide-formation)